Health Canada - Federal department responsible for drug approvals and health regulation in Canada
显示 2021 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| NRA-CANDESARTAN | nora pharma inc | Marketed | Nov 15, 2022 | Marketed |
| JAMP APREMILAST | Jamp Pharma Corporation | Marketed | Nov 14, 2022 | Marketed |
| PMS-APREMILAST | Pharmascience Inc | Marketed | Nov 14, 2022 | Marketed |
| JAMP APREMILAST | Jamp Pharma Corporation | Marketed | Nov 14, 2022 | Marketed |
| GLN-APREMILAST | glenmark pharmaceuticals canada inc. | Marketed | Nov 14, 2022 | Marketed |
| M-TICAGRELOR | mantra pharma inc | Marketed | Nov 11, 2022 | Marketed |
| TRANDOLAPRIL | sanis health inc | Marketed | Nov 10, 2022 | Marketed |
| TRANDOLAPRIL | sanis health inc | Marketed | Nov 10, 2022 | Marketed |
| APO-BRIMONIDINE-TIMOP | Apotex Inc | Marketed | Nov 9, 2022 | Marketed |
| DEXMEDESED | DECHRA VETERINARY PRODUCTS INC. | Marketed | Nov 7, 2022 | Marketed |
| APO-SITAGLIPTIN MALATE | Apotex Inc | Marketed | Nov 7, 2022 | Marketed |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | Apotex Inc | Marketed | Nov 7, 2022 | Marketed |
| APO-SITAGLIPTIN MALATE | Apotex Inc | Marketed | Nov 7, 2022 | Marketed |
| APO-SITAGLIPTIN/METFORMIN XR | Apotex Inc | Marketed | Nov 7, 2022 | Marketed |
| APO-SITAGLIPTIN/METFORMIN XR | Apotex Inc | Marketed | Nov 7, 2022 | Marketed |
| APO-SITAGLIPTIN MALATE | Apotex Inc | Marketed | Nov 7, 2022 | Marketed |
| APO-SITAGLIPTIN/METFORMIN XR | Apotex Inc | Marketed | Nov 7, 2022 | Marketed |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | Apotex Inc | Marketed | Nov 7, 2022 | Marketed |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | Apotex Inc | Marketed | Nov 7, 2022 | Marketed |
| TAVNEOS | vifor fresenius medical care renal pharma ltd | Marketed | Nov 4, 2022 | Marketed |
